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Introduction
Patients with peripheral arterial disease are at high risk of
cardiovascular events.
Purpose
Aim of this study was to assess the value of dobutamine
stress cardiovascular magnetic resonance (DCMR) for pre-
diction of cardiac events in patients with peripheral arte-
rial disease.
Methods
Clinical data and DCMR results were analyzed in patients
with peripheral arterial disease undergoing DCMR
between 2000 and 2004. Peripheral arterial disease was
defined as significant stenosis or occlusion of peripheral
arteries of the lower and upper extremity or of the carotid
artery. After an average of 35 ± 17 months, 140 patients
(median age, 65 years) were contacted and medical
records were reviewed. Wall motion abnormalities
(WMA) at rest and the presence of stress-induced WMA
(ischemia) were assessed for each patient. Cardiac events,
defined as cardiac death and non-fatal myocardial infarc-
tion, were assessed.
Results
Fifty two patients (37.1%) experienced an inducible WMA
during testing. Fifteen cardiac events were reported, car-
diac death in 13 and non-fatal myocardial infarction in 2
patients. In those with and without inducible WMA, the
proportion of patients with cardiac events were 17.3%
versus 6.8%, respectively, (hazard ratio: 3.8; 95% confi-
dence interval: 1.3 to 11.1 for the presence of inducible
WMA; p = 0.015). Patients without inducible WMA dem-
onstrated a relatively good prognosis, with a 48-months
event-free survival of 95.5%.
Conclusion
Patients with peripheral arterial disease have an increased
risk of cardiovascular events. In patients with generalized
arteriosclerosis, DCMR has an added value for predicting
cardiac events during long-term follow-up.
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